WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 561200
Description: JWH-073 is a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. Note: This product is supplied in methanol solution. JWH-073 is discontinued (DEA controlled substance).
MedKoo Cat#: 561200
Name: JWH-073 (methanol solution)
Chemical Formula: C23H21NO
Exact Mass: 327.1623
Molecular Weight: 327.427
Elemental Analysis: C, 84.37; H, 6.46; N, 4.28; O, 4.89
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 208987-48-8
Synonym: JWH-073; JWH073; JWH 073
IUPAC/Chemical Name: (1-Butyl-1H-indol-3-yl)-1-naphthalenyl-methanone
InChi Key: OTVLYTHPUXHDAQ-QNBGGDODSA-N
InChi Code: InChI=1S/C16H24ClN.ClH/c1-12(2)11-15(16-5-3-4-10-18-16)13-6-8-14(17)9-7-13;/h6-9,12,15-16,18H,3-5,10-11H2,1-2H3;1H/t15-,16-;/m1./s1
SMILES Code: CC(C)C[C@@H]([C@@H]1NCCCC1)C2=CC=C(Cl)C=C2.[H]Cl
Appearance: A solution in methanol
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 327.427 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014 Feb;46(1):86-95. doi: 10.3109/03602532.2013.849268. Epub 2013 Oct 25. Review. PubMed PMID: 24160757.
2: Presley BC, Jansen-Varnum SA, Logan BK. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings. Forensic Sci Rev. 2013 Mar;25(1-2):27-46. Review. PubMed PMID: 26226849.
3: Burillo-Putze G, Díaz BC, Pazos JL, Mas PM, Miró O, Puiguriguer J, Dargan P. [Emergent drugs (I): smart drugs]. An Sist Sanit Navar. 2011 May-Aug;34(2):263-74. Review. Spanish. PubMed PMID: 21904408.
4: Brents LK, Prather PL. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev. 2014 Feb;46(1):72-85. doi: 10.3109/03602532.2013.839700. Epub 2013 Sep 24. Review. PubMed PMID: 24063277; PubMed Central PMCID: PMC4100246.
5: Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, Impagnatiello M, Pascolo-Fabrici E, Bonavigo T. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol. 2013 Jul;28(4):379-89. doi: 10.1002/hup.2312. Review. PubMed PMID: 23881886.
6: Järbe TUC, Raghav JG. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man. Curr Top Behav Neurosci. 2017;32:263-281. doi: 10.1007/7854_2016_16. Review. PubMed PMID: 27753006.